MasterControl, a trusted and fully featured provider of quality and manufacturing software solutions for the life sciences. They include contract development and manufacturing, personalized medicine, and cell and gene therapy. MasterControl streamlines the collection and compilation of new product development documentation, integrates quality requirements early in the design process and manages design control throughout the product development lifecycle.
The company announced its first ever funding, a $150 million Series A round led by Sixth Street Growth. The company intends to use the funds to continue to enhance its solutions while also placing more focus on technology that will be able to predict and prevent quality events, and enable AI assisted manufacturing optimization.
The MasterControl Platform, Salt Lake City, Utah, United States, was founded by Jon Beckstrand in 1993. “For nearly three decades, we’ve been laser-focused on our mission to make life-changing products available to more people sooner. This commitment has led us to attack inefficiencies in quality and manufacturing that were extending product research and delivery cycles. We see an urgent need to help our customers to deliver their breakthrough technologies to the market faster and at a lower cost,” said Jon Beckstrand, CEO of MasterControl.
